According to Grandview Research, the hybrid and decentralized clinical trial (DCT) market will be worth more than 12 billion dollars by 2030.
In this free guide, we delve into the exciting world of DCTs and explore how they are reshaping the landscape of medical research. As technology advances and the need for more efficient and patient-centric approaches to clinical trials grows, DCTs have emerged as a powerful solution.
This guide serves as a roadmap for pharmaceutical companies, researchers, healthcare professionals, and anyone interested in understanding the fundamentals of decentralized clinical trials. Readers will walk away with an understanding of the various technologies deployed, their impact, what they mean for sites, participants, and the future of clinical research.
- What is a decentralized clinical trial?
- The rise of decentralized clinical trials
- Benefits and value drivers of DCTs
- Clinical trial recruitment
- Patient screening
- Electronic consent (eConsent)
- Clinical outcome assessments (COAs/eCOAs)